Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02406820 · ClinicalTrials.gov registry record
Correlating Noninvasive Cardiovascular Measures to Left Ventricular End Diastolic Pressure in Heart Failure
A clinical trial, sponsored by Intelomed.
- Terminated
- Registry status
- 1
- Enrollment target
NCT02406820: Clinical Trial study, sponsored by Intelomed.
NCT02406820 is a clinical trial that was terminated before completion, run by Intelomed. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02406820 was terminated before completion, sponsored by Intelomed.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
HF001 is a prospective observational study utilizing non-invasive medical devices that may be able to discriminate changes in heart failure while acutely decompensated patients undergo routine interventional therapies in a hospital setting. Subjects will be monitored using CVInsight™ \[CVI\] via a finger and/or forehead sensor, while performing an isometric handgrip stress test (IHGST). Changes in the CVI signal will be analyzed and correlated to standard assessments of heart failure including pulmonary artery catheter (PAC) pressures, blood pressure (BP), patient symptoms, and physical exam findings. The results of this study will be used to develop a powered study to determine if a new configuration of non-invasive monitoring devices can be used to monitor heart failure status more sensitively than current non-invasive techniques.
Interventions
- DEVICE Non-invasive hemodynamic monitoring (CVInsight™ [CVI])
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-03 |
Why NCT02406820 stopped before completion
NCT02406820 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Non-invasive hemodynamic monitoring (CVInsight™ [CVI]) is the first listed.
NCT02406820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02406820 about?
NCT02406820 is a clinical study titled "Correlating Noninvasive Cardiovascular Measures to Left Ventricular End Diastolic Pressure in Heart Failure". HF001 is a prospective observational study utilizing non-invasive medical devices that may be able to discriminate changes in heart failure while acutely decompensated patients undergo routine interventional therapies in a hospital setting. Subjects will be monitored using CVInsight™ \[CVI\] via a f...
What is the current status of trial NCT02406820?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2015-04. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02406820?
The interventions under investigation include: Non-invasive hemodynamic monitoring (CVInsight™ [CVI]) (DEVICE).
Who is sponsoring clinical trial NCT02406820?
This trial is sponsored by Intelomed, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia